MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 5.06
-0.02 (-0.39%)
Jan 12, 2026, 11:39 AM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €81.81 million as of January 12, 2026. Its market cap has decreased by -26.03% in one year.
Market Cap
81.81M
Enterprise Value
81.18M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.06
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 81.81M, a decrease of -38.36%. That is a compound annual growth rate of -10.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 81.81M | 5.61% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |